Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription


1 Arch Virol
1 BMC Cancer
1 BMC Gastroenterol
1 Clin Infect Dis
1 Gut
2 Hepatology
2 J Infect Dis
2 J Med Virol
3 J Viral Hepat
1 J Virol
1 Pediatr Infect Dis J
3 PLoS One
1 Proc Natl Acad Sci U S A
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Arch Virol

  1. SEDOHARA A, Takahashi K, Arai K, Arizono K, et al
    Characterization of mutations in hepatitis B virus DNA isolated from Japanese HBsAg-positive blood donors in 2021 and 2022.
    Arch Virol. 2024;169:103.
    PubMed         Abstract available

    BMC Cancer

  2. HAO X, Xu L, Lan X, Li B, et al
    Impact of hepatic inflammation and fibrosis on the recurrence and long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after hepatectomy.
    BMC Cancer. 2024;24:475.
    PubMed         Abstract available

    BMC Gastroenterol

  3. KRANIDIOTI H, Zisimopoulos K, Oikonomou T, Voulgaris T, et al
    Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study.
    BMC Gastroenterol. 2024;24:133.
    PubMed         Abstract available

    Clin Infect Dis

  4. HOOD RB, Norris AH, Shoben A, Miller WC, et al
    Forecasting Hepatitis C Virus Status for Children in the United States: A Modeling Study.
    Clin Infect Dis. 2024 Apr 17:ciae157. doi: 10.1093.
    PubMed         Abstract available


  5. THORNTON CS, Waddell BJ, Congly SE, Svishchuk J, et al
    Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients.
    Gut. 2024 Apr 15:gutjnl-2023-330602. doi: 10.1136/gutjnl-2023-330602.
    PubMed         Abstract available


  6. ZAHOOR MA, Feld JB, Lin HS, Mosa AI, et al
    Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN trials.
    Hepatology. 2024 Apr 17. doi: 10.1097/HEP.0000000000000878.
    PubMed         Abstract available

  7. SHENOY A, Fontana RJ
    HDV screening in chronic HBV: An unmet need of growing importance.
    Hepatology. 2024;79:979-982.

    J Infect Dis

  8. BEGRE L, Boyd A, Plissonnier ML, Testoni B, et al
    Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy.
    J Infect Dis. 2024 Apr 16:jiae189. doi: 10.1093.
    PubMed         Abstract available

  9. SCHMIDT S, Mengistu M, Daffis S, Ahmadi-Erber S, et al
    Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus-Specific CD8 T-Cell Responses and High Anti-Hepatitis B Surface Antigen Titers.
    J Infect Dis. 2024;229:1077-1087.
    PubMed         Abstract available

    J Med Virol

  10. CHEN L, Tao X, Zeng M, Li Y, et al
    Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver disease.
    J Med Virol. 2024;96:e29613.
    PubMed         Abstract available

  11. HOU L, Zhao J, Cai L, Jin L, et al
    HBV PreC interacts with SUV39H1 to induce viral replication by blocking the proteasomal degradation of viral polymerase.
    J Med Virol. 2024;96:e29607.
    PubMed         Abstract available

    J Viral Hepat

  12. OLTMANNS C, Bremer B, Kusche L, Stal P, et al
    Elevation of S2-bound alpha1-acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma.
    J Viral Hepat. 2024 Apr 12. doi: 10.1111/jvh.13943.
    PubMed         Abstract available

  13. WONG RJ, Hirode G, Feld J, Wong SS, et al
    An updated assessment of hepatitis delta prevalence among adults in Canada: A meta-analysis.
    J Viral Hepat. 2024 Apr 15. doi: 10.1111/jvh.13939.
    PubMed         Abstract available

  14. ALQAHTANI SA, Yilmaz Y, El-Kassas M, Alswat K, et al
    Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt.
    J Viral Hepat. 2024 Apr 15. doi: 10.1111/jvh.13935.
    PubMed         Abstract available

    J Virol

  15. SCHOLLMEIER A, Basic M, Glitscher M, Hildt E, et al
    The impact of HBx protein on mitochondrial dynamics and associated signaling pathways strongly depends on the hepatitis B virus genotype.
    J Virol. 2024 Apr 17:e0042424. doi: 10.1128/jvi.00424.
    PubMed         Abstract available


    What Is Hepatitis D Infection?
    JAMA. 2024 Apr 18. doi: 10.1001/jama.2024.1317.

    Pediatr Infect Dis J

  17. MORRIS N, Hunter K, Bhat V, Kushnir A, et al
    Hepatitis C Exposure Diagnosis and Testing in Infants Born to Hepatitis C Virus-infected Mothers.
    Pediatr Infect Dis J. 2024 Apr 10. doi: 10.1097/INF.0000000000004355.
    PubMed         Abstract available

    PLoS One

  18. DEBSIKREO N, Mankreo BL, Moukenet A, Ouangkake M, et al
    Prevalence of hepatitis B virus infection and its associated factors among students in N'Djamena, Chad.
    PLoS One. 2024;19:e0273589.
    PubMed         Abstract available

  19. TADESSE K, Ayalew G, Million Y, Gelaw A, et al
    Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia.
    PLoS One. 2024;19:e0301973.
    PubMed         Abstract available

  20. SENOO-DOGBEY VE, Anto F, Quansah R, Danso-Appiah A, et al
    Completion of three-dose hepatitis B vaccination cycle and associated factors among health care workers in the Greater Accra Region of Ghana.
    PLoS One. 2024;19:e0298771.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  21. PAPINI C, Ullah I, Ranjan AP, Zhang S, et al
    Proof-of-concept studies with a computationally designed M(pro) inhibitor as a synergistic combination regimen alternative to Paxlovid.
    Proc Natl Acad Sci U S A. 2024;121:e2320713121.
    PubMed         Abstract available


  22. TU T, Wettengel J, Xia Y, Testoni B, et al
    Major open questions in the hepatitis B and D field - Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop.
    Virology. 2024;595:110089.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.